{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T06:34:54Z","timestamp":1778567694889,"version":"3.51.4"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,9,22]],"date-time":"2013-09-22T00:00:00Z","timestamp":1379808000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Mol Neurosci"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1007\/s12031-013-0115-4","type":"journal-article","created":{"date-parts":[[2013,9,21]],"date-time":"2013-09-21T06:13:20Z","timestamp":1379744000000},"page":"598-604","source":"Crossref","is-referenced-by-count":5,"title":["Interaction of Different Antidepressants with Acute and Chronic Methadone in Mice, and Possible Clinical Implications"],"prefix":"10.1007","volume":"52","author":[{"given":"Shaul","family":"Schreiber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yonatan","family":"Barak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avner","family":"Hostovsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renana","family":"Baratz-Goldstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ina","family":"Volis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vardit","family":"Rubovitch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaim G.","family":"Pick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,9,22]]},"reference":[{"key":"115_CR1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejpain.2004.03.003","volume":"9","author":"M Aragona","year":"2005","unstructured":"Aragona M, Bancheri L, Perinelli D, Tarsitani L, Pizzimenti A, Conte A, Inghilleri M (2005) Randomized double-blind comparison of serotonergic (Citalopram) versus noradrenergic (Reboxetine) reuptake inhibitors in outpatients with somatoform, DSM-IV-TR pain disorder. Eur J Pain 9:33\u201338","journal-title":"Eur J Pain"},{"key":"115_CR2","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1124\/jpet.110.169276","volume":"335","author":"ML Banks","year":"2010","unstructured":"Banks ML, Rice KC, Negus SS (2010) Antinociceptive interactions between Mu-opioid receptor agonists and the serotonin uptake inhibitor clomipramine in rhesus monkeys: role of Mu agonist efficacy. J Pharmacol Exp Ther 335:497\u2013505","journal-title":"J Pharmacol Exp Ther"},{"key":"115_CR3","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3109\/10401239309148983","volume":"5","author":"CM Beasley Jr","year":"1993","unstructured":"Beasley CM Jr, Holman SL, Potvin JH (1993) Fluoxetine compared with imipramine in the treatment of inpatient depression. A multicenter trial. Ann Clin Psychiatry 5:199\u2013207","journal-title":"Ann Clin Psychiatry"},{"key":"115_CR4","doi-asserted-by":"crossref","first-page":"9040","DOI":"10.1523\/JNEUROSCI.20-24-09040.2000","volume":"20","author":"LM Bohn","year":"2000","unstructured":"Bohn LM, Xu F, Gainetdinov RR, Caron MG (2000) Potentiated opioid analgesia in norepinephrine transporter knock-out mice. J Neurosci 20:9040\u20139045","journal-title":"J Neurosci"},{"key":"115_CR5","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0893-133X(01)00298-6","volume":"25","author":"FP Bymaster","year":"2001","unstructured":"Bymaster FP, Dreshfield-Ahmad LJ, Threlkeld PG, Shaw JL, Thompson L, Nelson DL, Hemrick-Luecke SK, Wong DT (2001) Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors. Neuropsychopharmacology 25:871\u2013880","journal-title":"Neuropsychopharmacology"},{"key":"115_CR6","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.euroneuro.2004.08.008","volume":"15","author":"F Chen","year":"2005","unstructured":"Chen F, Larsen MB, Sanchez C, Wiborg O (2005) The S-enantiomer of R, S-citalopram, increases inhibitor binding to the human serotonin transporter by an allosteric mechanism. Comparison with other serotonin transporter inhibitors. Eur Neuropsychopharmacol 15:193\u2013198","journal-title":"Eur Neuropsychopharmacol"},{"key":"115_CR7","doi-asserted-by":"crossref","unstructured":"Cookson J (1993) Side-effects of antidepressants. Br J Psychiatry 20 (Suppl. July):20\u201324","DOI":"10.1192\/S0007125000292325"},{"key":"115_CR8","first-page":"3000","volume":"51","author":"VL Ellingrod","year":"1994","unstructured":"Ellingrod VL, Perry PJ (1994) Venlafaxine: a heterocyclic antidepressant. Am J Hosp Pharm 51:3000\u20133046","journal-title":"Am J Hosp Pharm"},{"key":"115_CR9","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1089\/15246090260137635","volume":"11","author":"EW Freeman","year":"2002","unstructured":"Freeman EW, Jabara S, Sondheimer SJ, Auletto R (2002) Citalopram in PMS patients with prior SSRI treatment failure: a preliminary study. J Women\u2019s Health Gend -Based Med 11:459\u2013564","journal-title":"J. Women\u2019s Health Gend. -Based Med."},{"key":"115_CR10","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/j.1365-2125.2011.04145.x","volume":"73","author":"EA Gelston","year":"2012","unstructured":"Gelston EA, Coller JK, Lopatko OV, James HM, Schmidt H, White JM, Somogyi AA (2012) Methadone inhibits CYP2D6 and UGT2B7\/2B4 in vivo: a study using codeine in methadone- and buprenorphine-maintained subjects. Br J Clin Pharmacol 73:786\u2013794","journal-title":"Br J Clin Pharmacol"},{"key":"115_CR11","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/bja\/aei210","volume":"95","author":"PK Gillman","year":"2005","unstructured":"Gillman PK (2005) Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity. Br J Anaesth 95:434\u2013441","journal-title":"Br J Anaesth"},{"key":"115_CR12","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jamda.2005.04.012","volume":"6","author":"N Gnanadesigan","year":"2005","unstructured":"Gnanadesigan N, Espinoza RT, Smith R, Israel M, Reuben DB (2005) Interaction of serotonergic antidepressants and opioid analgesics: is serotonin syndrome going undetected? J Am Med Dir Assoc 6:265\u2013269","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"115_CR13","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2165\/00023210-199912010-00006","volume":"12","author":"KJ Holm","year":"1999","unstructured":"Holm KJ, Spencer CM (1999) Reboxetine. CNS Drugs 12:65\u201383","journal-title":"CNS Drugs"},{"issue":"Suppl 1","key":"115_CR14","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/0024-3205(83)90529-5","volume":"33","author":"MJ Kreek","year":"1983","unstructured":"Kreek MJ, Wardlaw SL, Hartman N, Raghunath J, Friedman J, Schneider B, Frantz AG (1983) Circadian rhythms and levels of beta-endorphin, ACTH, and cortisol during chronic methadone maintenance treatment in humans. Life Sci 33(Suppl 1):409\u2013411","journal-title":"Life Sci"},{"key":"115_CR15","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.genhosppsych.2008.12.006","volume":"31","author":"K Kroenke","year":"2009","unstructured":"Kroenke K, Krebs EE, Bair MJ (2009) Pharmacotherapy of chronic pain: a synthesis of recommendations from systematic reviews. Gen Hosp Psychiatry 31:206\u2013219","journal-title":"Gen Hosp Psychiatry"},{"key":"115_CR16","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.forsciint.2011.11.006","volume":"217","author":"E Lendoiro","year":"2012","unstructured":"Lendoiro E, Quintela O, de Castro A, Cruz A, L\u00f3pez-Rivadulla M, Concheiro M (2012) Target screening and confirmation of 35 licit and illicit drugs and metabolites in hair by LC-MSMS. Forensic Sci Int 217:207\u2013215","journal-title":"Forensic Sci Int"},{"key":"115_CR17","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0022-3565(25)30314-9","volume":"195","author":"SJ Liu","year":"1975","unstructured":"Liu SJ, Wang RI (1975) Increased analgesia and alterations in distribution and metabolism of methadone by desipramine in the rat. J Pharmacol Exp Ther 195:94\u2013104","journal-title":"J Pharmacol Exp Ther"},{"key":"115_CR18","doi-asserted-by":"crossref","unstructured":"Lloyd GK, Cronin S, Fletcher A, Mitchell PJ (1992) The profile of venlafaxine, a novel antidepressant agent, in behavioral antidepressant drug models. Clin Neuropharm 15(Suppl 1; part B), 428B","DOI":"10.1097\/00002826-199202001-00831"},{"key":"115_CR19","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jpain.2010.07.006","volume":"12","author":"J Mao","year":"2011","unstructured":"Mao J, Gold MS, Backonja MM (2011) Combination drug therapy for chronic pain: a call for more clinical studies. J Pain 12:157\u2013166","journal-title":"J. Pain"},{"key":"115_CR20","first-page":"105","volume":"68","author":"C Mattia","year":"2002","unstructured":"Mattia C, Paoletti F, Coluzzi F, Boanelli A (2002) New antidepressants in the treatment of neuropathic pain. A review. Minerva Anestesiol 68:105\u2013114","journal-title":"Minerva Anestesiol"},{"key":"115_CR21","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/0028-3908(75)90043-X","volume":"14","author":"VL Mehta","year":"1975","unstructured":"Mehta VL (1975) Cholinergic mechanisms in narcotic analgesics. Neuropharmacology 14:893\u2013901","journal-title":"Neuropharmacology"},{"issue":"suppl 2","key":"115_CR22","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/00004850-199503002-00003","volume":"10","author":"J Mendlewicz","year":"1995","unstructured":"Mendlewicz J (1995) Pharmacologic profile and efficacy of venlafaxine. Int Clin Psychopharmacol 10(suppl 2):5\u201313","journal-title":"Int Clin Psychopharmacol"},{"key":"115_CR23","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1017\/S0317167100004236","volume":"32","author":"DE Moulin","year":"2005","unstructured":"Moulin DE, Palma D, Watling C, Schulz V (2005) Methadone in the management of intractable neuropathic noncancer pain. Can J Neurol Sci 32:340\u2013343","journal-title":"Can J Neurol Sci"},{"key":"115_CR24","doi-asserted-by":"crossref","unstructured":"Moyer JA, Andree TH, Haskins JT, Husbands GEM, Muth EA (1992) The preclinical pharmacological profile of venlafaxine: a novel antidepressant agent. Clin Neuropharm 15(Suppl. 1; part B):435B","DOI":"10.1097\/00002826-199202001-00845"},{"key":"115_CR25","doi-asserted-by":"crossref","first-page":"4493","DOI":"10.1016\/0006-2952(86)90769-0","volume":"35","author":"EA Muth","year":"1986","unstructured":"Muth EA, Haskins JT, Moyer JA, Husbands GEM, Nielsen ST, Sigg EB (1986) Antidepressant biochemical profile of the novel bicyclic compound Wy-45,030, an ethyl cyclohexanol derivative. Biochem Pharmacol 35:4493\u20134497","journal-title":"Biochem Pharmacol"},{"key":"115_CR26","unstructured":"NIH Consensus Statement (1997) Effective medical treatment of opiate addiction. November 17\u201319, 15, 6"},{"key":"115_CR27","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1001\/jama.291.15.1887","volume":"291","author":"EV Nunes","year":"2004","unstructured":"Nunes EV, Levin FR (2004) Treatment of depression in patients with alcohol or other drug dependence: a meta-analysis. JAMA 291:1887\u20131896","journal-title":"JAMA"},{"key":"115_CR28","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.biopsych.2004.06.037","volume":"56","author":"EV Nunes","year":"2004","unstructured":"Nunes EV, Sullivan MA, Levin FR (2004) Treatment of depression in patients with opiate dependence. Biol Psychiatry 56:793\u2013802","journal-title":"Biol Psychiatry"},{"key":"115_CR29","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s12576-012-0207-x","volume":"62","author":"E Ozdemir","year":"2012","unstructured":"Ozdemir E, Gursyoy S, Bagcivan I (2012) The effects of serotonin\/norepinephrine reuptake inhibitors and serotonin receptor agonist on morphine analgesia and tolerance in rats. J Physiol Sci 62:317\u2013323","journal-title":"J Physiol Sci"},{"key":"115_CR30","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/JCP.0b013e31822c0adf","volume":"31","author":"P Pedrelli","year":"2011","unstructured":"Pedrelli P, Iovieno N, Vitali M, Tedeschini E, Bentley KH, Papakostas GI (2011) Treatment of major depressive disorder and dysthymic disorder with antidepressants in patients with comorbid opiate use disorders enrolled in methadone maintenance therapy \u2014 a meta-analysis. J Clin Psychopharmacol 31:582\u2013586","journal-title":"J Clin Psychopharmacol"},{"key":"115_CR31","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.euroneuro.2007.10.001","volume":"18","author":"E Peles","year":"2008","unstructured":"Peles E, Schreiber S, Adelson M (2008) Tricyclic antidepressants abuse, with or without benzodiazepines abuse, in former heroin addicts currently in methadone maintenance treatment (MMT). Eur Neuropsychopharmacol 18:188\u2013193","journal-title":"Eur Neuropsychopharmacol"},{"key":"115_CR32","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jad.2006.09.017","volume":"99","author":"E Peles","year":"2007","unstructured":"Peles E, Schreiber S, Naumovsky Y, Adelson M (2007) Depression in methadone maintenance treatment patients: rate and risk factors. J Affect Disord 99:213\u2013220","journal-title":"J Affect Disord"},{"key":"115_CR33","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0014-2999(92)90395-K","volume":"211","author":"CG Pick","year":"1992","unstructured":"Pick CG, Paul D, Eison MS, Pasternak GW (1992) Potentiation of opioid analgesia by the antidepressant nefazodone. Eur J Pharmacol 211:375\u2013381","journal-title":"Eur J Pharmacol"},{"key":"115_CR34","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s12024-010-9188-3","volume":"7","author":"JL Pilgrim","year":"2011","unstructured":"Pilgrim JL, Gerostamoulos D, Drummer OH (2011) Review: pharmacogenetic aspects of the effect of cytochrome P450 polymorphisms on serotonergic drug metabolism, response, interactions, and adverse effects. Forensic Sci Med Pathol 7:162\u2013184","journal-title":"Forensic Sci. Med. Pathol."},{"key":"115_CR35","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1192\/bjp.163.1.105","volume":"163","author":"P Power-Smith","year":"1993","unstructured":"Power-Smith P, Turkington D (1993) Fluoxetine in phantom limb pain. Br J Psychiatry 163:105\u2013106","journal-title":"Br J Psychiatry"},{"issue":"suppl 2","key":"115_CR36","doi-asserted-by":"crossref","first-page":"1S","DOI":"10.1097\/00004714-199606002-00001","volume":"16","author":"E Richelson","year":"1996","unstructured":"Richelson E (1996) Synaptic effects of antidepressants. J Clin Psychopharmacol 16(suppl 2):1S\u20139S","journal-title":"J Clin Psychopharmacol"},{"key":"115_CR37","doi-asserted-by":"crossref","unstructured":"Saarto T, Wiffen PJ (2007) Antidepressants for neuropathic pain. Cochrane Database Syst Rev; Issue 4. Art. No.: CD005454. doi: 10.1002\/14651858.CD005454.pub2","DOI":"10.1002\/14651858.CD005454.pub2"},{"key":"115_CR38","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1526-4610.1994.hed3409497.x","volume":"34","author":"JR Saper","year":"1994","unstructured":"Saper JR, Silberstein SD, Lake AE 3rd, Winters ME (1994) Double-blind trial of fluoxetine: chronic daily headache and migraine. Headache 34:497\u2013502","journal-title":"Headache"},{"key":"115_CR39","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0304-3940(99)00627-8","volume":"273","author":"S Schreiber","year":"1999","unstructured":"Schreiber S, Backer MM, Pick CG (1999) The antinociceptive effect of venlafaxine in mice is mediated through opioid and adrenergic mechanisms. Neurosci Lett 273:85\u201388","journal-title":"Neurosci Lett"},{"key":"115_CR40","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0924-977X(96)00031-4","volume":"6","author":"S Schreiber","year":"1996","unstructured":"Schreiber S, Backer MM, Yanai J, Pick CG (1996) The antinociceptive effect of fluvoxamine. Eur Neuropsychopharmacol 6:281\u2013284","journal-title":"Eur Neuropsychopharmacol"},{"key":"115_CR41","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1385\/JMN:18:1-2:143","volume":"18","author":"S Schreiber","year":"2002","unstructured":"Schreiber S, Bleich A, Pick CG (2002) Venlafaxine and mirtazapine: different mechanisms of antidepressant action, common opioid-mediated antinociceptive effects - a possible opioid involvement in severe depression? J Mol Neurosci 18:143\u2013149","journal-title":"J Mol Neurosci"},{"key":"115_CR42","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.euroneuro.2009.06.004","volume":"19","author":"S Schreiber","year":"2009","unstructured":"Schreiber S, Frishtick R, Volis I, Rubovitch V, Pick CG, Weizman R (2009) The antinociceptive properties of reboxetine in acute pain. Eur Neuropsychopharmacol 19:735\u2013739","journal-title":"Eur Neuropsychopharmacol"},{"key":"115_CR43","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/00005053-199511000-00010","volume":"18","author":"S Schreiber","year":"1995","unstructured":"Schreiber S, Pick CG (1995) Fluoxetine for blepharospasm: interaction of serotonin and dopamine. J Nerv Ment Dis 18:719\u2013721","journal-title":"J Nerv Ment Dis"},{"key":"115_CR44","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/00005053-199707000-00009","volume":"187","author":"S Schreiber","year":"1997","unstructured":"Schreiber S, Pick CG (1997) Paroxetine for secondary stuttering: further interaction of serotonin and dopamine. J Nerv Ment Dis 187:465\u2013467","journal-title":"J Nerv Ment Dis"},{"key":"115_CR45","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.euroneuro.2005.11.013","volume":"16","author":"S Schreiber","year":"2006","unstructured":"Schreiber S, Pick CG (2006) From selective to highly-selective SSRIs: a comparison of the antinociceptive properties of fluoxetine, fluvoxamine, citalopram and escitalopram. Eur Neuropsychopharmacol 16:464\u2013468","journal-title":"Eur. Neuropsychopharmacol"},{"key":"115_CR46","first-page":"88","volume":"38","author":"S Schreiber","year":"2001","unstructured":"Schreiber S, Vinokur S, Shavelzon V, Pick CG, Shir Y (2001) The use of fluoxetine for chronic pain management: a six weeks comparison study with amitriptyline. Isr J Psychiatry Relat Sci 38:88\u201394","journal-title":"Isr J Psychiatry Relat Sci"},{"key":"115_CR47","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1080\/00207450290026139","volume":"112","author":"M Shimodozono","year":"2002","unstructured":"Shimodozono M, Kawahira K, Kamishita T, Ogata A, Tohgo S, Tanaka N (2002) Reduction of central poststroke pain with the selective serotonin reuptake inhibitor fluvoxamine. Int J Neurosci 112:1173\u20131181","journal-title":"Int J Neurosci"},{"key":"115_CR48","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0304-3959(90)91157-E","volume":"42","author":"SH Sindrup","year":"1990","unstructured":"Sindrup SH, Gram LF, Brosen K, Eshoj O, Mogensen EF (1990) The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain 42:135\u2013144","journal-title":"Pain"},{"key":"115_CR49","doi-asserted-by":"crossref","first-page":"454","DOI":"10.2165\/00003088-199733060-00004","volume":"33","author":"BA Sproule","year":"1997","unstructured":"Sproule BA, Naranjo CA, Brenmer KE, Hassan PC (1997) Selective serotonin reuptake inhibitors and CNS drug interactions. A critical review of the evidence. Clin Pharmacokinet 33:454\u2013471","journal-title":"Clin Pharmacokinet"},{"key":"115_CR50","first-page":"343","volume":"59","author":"SM Stahl","year":"1998","unstructured":"Stahl SM (1998a) Not so selective serotonin reuptake inhibitors. J Clin Psychiatry 59:343\u2013344","journal-title":"J Clin Psychiatry"},{"key":"115_CR51","doi-asserted-by":"crossref","first-page":"642","DOI":"10.4088\/JCP.v59n1201","volume":"59","author":"SM Stahl","year":"1998","unstructured":"Stahl SM (1998b) Using secondary binding properties to select a not so selective serotonin reuptake inhibitor. J Clin Psychiatry 59:642\u2013643","journal-title":"J Clin Psychiatry"},{"key":"115_CR52","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0014-2999(97)01393-9","volume":"340","author":"M Tatsumi","year":"1997","unstructured":"Tatsumi M, Groshan K, Blakely RD, Richelson E (1997) Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol 340:249\u2013258","journal-title":"Eur J Pharmacol"},{"key":"115_CR53","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/j.1476-5381.2011.01297.x","volume":"163","author":"AS Wattiez","year":"2011","unstructured":"Wattiez AS, Libert F, Privat AM, Loiodice S, Fialip J, Eschalier A, Courteix C (2011) Evidence for a differential opioidergic involvement in the analgesic effect of antidepressants: prediction for efficacy in animal models of neuropathic pain? Br J Pharmacol 163:792\u2013803","journal-title":"Br J Pharmacol"},{"key":"115_CR54","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0024-3205(95)00209-O","volume":"57","author":"DT Wong","year":"1995","unstructured":"Wong DT, Bymaster FP, Engleman EA (1995) Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: twenty years since its first publication. Life Sci 57:411\u2013441","journal-title":"Life Sci"}],"container-title":["Journal of Molecular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-013-0115-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12031-013-0115-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-013-0115-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T14:48:30Z","timestamp":1746024510000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12031-013-0115-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,22]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["115"],"URL":"https:\/\/doi.org\/10.1007\/s12031-013-0115-4","relation":{},"ISSN":["0895-8696","1559-1166"],"issn-type":[{"value":"0895-8696","type":"print"},{"value":"1559-1166","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,22]]}}}